Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
RTOG 0617 CETUXIMAB and/or PACLITAXEL STUDY AGENT SHIPMENT FORM (SASF) Cetuximab will be provided for both U.S. and Canadian sites/Paclitaxel will only be provided to Canadian sites. “A Randomized Phase III Comparison of Standard- Dose (60 Gy) Versus High-Dose (74 Gy) Conformal Radiotherapy with Concurrent and Consolidation Carboplatin/Paclitaxel +/- Cetuximab (IND #103444) in Patients with Stage IIIA/IIIB NonSmall Cell Lung Cancer” A patient-specific supply of the study agent(s) will be shipped by Biologics, Inc., only to institutions that have identified a single individual as responsible for receipt and accountability of shipments, who have completed and submitted this Study Agent Shipment Form (SASF). This form should be completed electronically (versus handwritten for improved legibility) then faxed by U.S. and Canadian Institutions to the CTSU Regulatory Office (Fax 215-569-0206) as soon as the individual responsible for the study agent has been identified. International institutions must submit the Study Agent Shipment Form to RTOG headquarters (Fax 215-574-0300) only after receiving written approval of the submitted LOI from RTOG HQ. NOTE: The SASF requires submission only once. The SASF must be processed before the institution is approved to receive drug. Institutions should allow adequate time (7-10 days) for form processing before registering the first case. Patient registration, not submission of the SASF, triggers the initial drug shipment. See Section 7.0 of the protocol under the “Supply” and “Drug Ordering and Accountability” headings for details regarding anticipated shipment and delivery timeframes. Please review Section 5.0 of the protocol to assure that you have met and understand all pre-registration requirements before calling to register your first case. (To increase legibility and prevent shipping problems, it is preferred that this form be completed electronically. It can then be printed out for the Investigator to sign and faxed or mailed to the appropriate entity) Shipping Information (all information noted in red is required) Name and Title of Responsible Party Street Address (No P.O. Boxes) City, State, Zip Code Telephone Number Fax Number E-mail Address Cooperative Group Affiliation for Registration (Please select only one) RTOG Institution Number CTEP/NCI Code Institution Name Initial IRB Approval Date (mm/dd/yyyy) CALGB NCIC CTSU NSABP / / Approval Pending ECOG RTOG GOG SWOG RTOG HQ Confirmation Investigator Name Investigator NCI Number Investigator Signature Send completed forms from U.S. & Canadian sites to: CTSU Regulatory Office 1818 Market Street, Suite 1100 Philadelphia, PA 19103 FAX 215-569-0206 RTOG Headquarters Approval Version 1/2007 NCCTG Date Send completed forms from APPROVED International sites to: RTOG HQ 1818 Market Street, Suite 1600 Philadelphia, PA 19103 FAX 215-574-0300 Date